GB Sciences, Inc. (OTCMKTS:GBLX) Short Interest Down 51.2% in June

GB Sciences, Inc. (OTCMKTS:GBLXGet Rating) was the target of a large decline in short interest in June. As of June 15th, there was short interest totalling 23,700 shares, a decline of 51.2% from the May 31st total of 48,600 shares. Based on an average daily volume of 174,900 shares, the short-interest ratio is currently 0.1 days.

Shares of OTCMKTS:GBLX traded up $0.00 on Friday, reaching $0.02. The company had a trading volume of 18,610 shares, compared to its average volume of 217,690. GB Sciences has a 52-week low of $0.02 and a 52-week high of $0.06. The firm’s 50 day simple moving average is $0.03 and its 200-day simple moving average is $0.03.

GB Sciences Company Profile (Get Rating)

GB Sciences, Inc engages in the research and development of cannabinoid medicines in North America and Europe. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc and changed its name to GB Sciences, Inc in October 2016.

See Also

Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.